Comparison of orally administered bisphosphonate drugs in reducing the risk of hip fracture in older adults: a population-based cohort study

BACKGROUND: Orally administered bisphosphonate drugs (i.e., alendronate, etidronate, risedronate) can reduce the risk of vertebral fracture. However, only alendronate and risedronate have proven efficacy in reducing the risk of hip fracture. We sought to examine the comparative effectiveness of oral...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cadarette, Suzanne M., Lévesque, Linda, Mamdani, Muhammad, Perreault, Sylvie, Juurlink, David N., Paterson, J. Michael, Carney, Greg, Gunraj, Nadia, Hawker, Gillian A., Tadrous, Mina, Wong, Lindsay, Dormuth, Colin R.
Formato: Artigo
Idioma:Inglês
Publicado em: Canadian Medical Association 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3986012/
https://ncbi.nlm.nih.gov/pubmed/25077113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9778/cmajo.20130036
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados